Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced that the U.S.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced the launch of the generic equivalent to INTUNIV® (guanfacine) 1 mg, 2 mg, 3 mg, and 4 …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announces the launch of the generic equivalent to Actonel® (risedronate sodium) Tablets, 5 mg, 30 mg, and 35 …
You have chosen to follow this author. You will receive an email notification when this author publishes a new article.
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announces the launch of the generic equivalent of Lomedia® 24 Fe (norethindrone acetate and ethinyl estradiol tablets …
World Multiple Sclerosis Day, Jack Osbourne, in partnership with Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), kicked off the third year of the You Don’t …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that three company-sponsored abstracts will be presented at the 2015 American Thoracic Society (ATS) International Conference in …
Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) announced the presentation of further data from its chronic migraine phase 2b study evaluating the efficacy and safety, versus …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that the acquisition of Auspex Pharmaceuticals, Inc. (NASDAQ: ASPX) has been completed through the successful tender offer …
Teva Pharmaceutical Industries Ltd (ADR)(NYSE:TEVA) announced that an updated investor presentation in connection with its proposed combination with Mylan N.V.
